Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

8.59USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.59
Open
$8.54
Day's High
$8.64
Day's Low
$8.35
Volume
31,226
Avg. Vol
38,829
52-wk High
$19.00
52-wk Low
$7.89

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.71 December 18 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.84 1.70 0.20 --
Quarter Ending Mar-19 1 2.00 2.00 2.00 --
Year Ending Dec-18 5 3.16 3.80 2.42 --
Year Ending Dec-19 6 9.74 18.12 1.04 --
Earnings (per share)
Quarter Ending Dec-18 6 -0.71 -0.53 -0.85 --
Quarter Ending Mar-19 1 -0.78 -0.78 -0.78 --
Year Ending Dec-18 5 -2.73 -2.42 -2.94 --
Year Ending Dec-19 6 -3.34 -2.69 -4.06 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.94 0.46 1.47 76.10
Quarter Ending Mar-18 0.28 1.15 0.87 311.79
Quarter Ending Dec-17 0.33 0.99 0.66 198.83
Quarter Ending Sep-17 0.20 0.60 0.40 203.51

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.84 0.76 0.76 0.76 --
Quarter Ending Mar-19 2.00 2.00 2.00 2.00 --
Year Ending Dec-18 3.16 2.98 2.98 2.98 --
Year Ending Dec-19 9.74 8.91 8.91 8.91 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 1 0 1 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 1 0 1 0
Year Ending Dec-19 1 0 1 0
Earnings